(PharmaNewsWire.Com, July 31, 2019 ) The growth of the market is attributed to the growth in female geriatric population and the rising incidence of gynecological diseases; increasing adoption of minimally invasive treatments; implementation of favorable government initiatives and the increasing adoption of office hysteroscopy.
The Hysteroscopy Instruments market is expected to reach USD 1.89 Billion by 2022 from USD 1.30 Billion in 2017, at a CAGR of 7.8%.
+ Market Dynamics
+ Drivers
+ Growth in Female Geriatric Population and Rising Incidence of Gynecological Diseases
+ Increasing Adoption of Minimally Invasive Treatments
The hysteroscopy instruments market is segmented into handheld instruments, hysteroscopes, resectoscopes, hysterosheaths, fluid management systems, and tissue removal systems. In 2017, the hysteroscopes segment is expected to account for the largest share of the hysteroscopy instruments market. The rising incidence of gynecological diseases and the increasing female geriatric population are the major factors driving the growth of the market.
The hysteroscopy instruments market is segmented into diagnostic hysteroscopy and operative hysteroscopy. The diagnostic hysteroscopy segment is expected to grow at the highest rate during the forecast period. The increasing incidence of uterine abnormalities is a major factor driving the demand for diagnostic hysteroscopy.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
